Patients presenting an indication for IVF or IVF-ICSI were assigned into either the Treatment Group - GnRH antagonist protocol , programmed to start stimulatory agents on a Friday , with oral @mg estradiol valerate twice a day from the @nd day of cycle until the first Friday to follow , or to the Control Group - long luteal GnRH agonist protocol .